 |
 |

Anemia in Hemodialysis PatientsChanging Concepts in Management
Michael R. Higgins, MB, ChB, FRCP(C), FRCP(Edin);
Michael Grace, PhD, PEng;
Raymond A. Ulan, MD, FRCP(C);
Donald S. Silverberg, MD, FRCP(C);
Kelvin B. Bettcher, MB, BS, FRCP(C);
John B. Dossetor, MD, FACP, FRCP(C)
Arch Intern Med. 1977;137(2):172-176.
Abstract
The association between anemia and chronic renal failure has been recognized since the early 19th century. With the introduction of regular dialysis treatment, an understanding of all aspects of this uremic complication has become of great importance, including an appreciation of the hazards of multiple blood transfusions. This analysis of hemoglobin levels and transfusion requirements in 84 dialysis patients focuses specific attention on hemolytic mechanisms, blood loss, and the effect of bilateral nephrectomy on erythropoiesis.
Because no replacement for renal erythropoietin is available, particular attention must be paid to less important, but partially correctable factors that contribute to anemia. Blood transfusion requirements can then be reduced to a minimum, together with the risks of hypersplenism, hepatitis, and sensitization of the patient to alloantigens.
(Arch Intern Med 137:172-176, 1977)
Author Affiliations
From the University of Alberta, Edmonton, Alberta, Canada (Drs Higgins, Silverberg, Bettcher, and Dossetor); the W. W. Cross Cancer Institute, Edmonton, Alberta, Canada (Dr Grace); and the University Hospital, London, Ontario, Canada (Dr Ulan).
Footnotes
Accepted for publication May 18, 1976.
Reprint requests to University Hospital, Room 3205, Edmonton, Alberta T6G 2B7, Canada (Dr Higgins).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Blood transfusion use in non-dialysis-dependent chronic kidney disease patients aged 65 years and older
Ibrahim et al.
Nephrol Dial Transplant 2009;24:3138-3143.
ABSTRACT
| FULL TEXT
Erythropoietin Therapy, Hemoglobin Targets, and Quality of Life in Healthy Hemodialysis Patients: A Randomized Trial
Foley et al.
CJASN 2009;4:726-733.
ABSTRACT
| FULL TEXT
Hemoglobin Targets and Blood Transfusions in Hemodialysis Patients without Symptomatic Cardiac Disease Receiving Erythropoietin Therapy
Foley et al.
CJASN 2008;3:1669-1675.
ABSTRACT
| FULL TEXT
Medical Management of Home Hemodialysis Patients
WRIGHT and MYERS
ANN INTERN MED 1978;89:367-372.
ABSTRACT
|